Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COGNEX CORPCGNX · Entity 3527 | Director | February 21, 2026 | February 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COGNEX CORP
Report date February 21, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,222 |
Ending reported balance
After 2026-02-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-21 · Exercise / conversion · Acquired 2,537 · Balance 20,372 Row 2 · 2026-02-23 · Sale · Disposed 4,150 · Balance 16,222 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-02-21 | Direct | 0 |
Reported balance
After 2026-02-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-21 · Exercise / conversion · Disposed 2,537 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F2: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-02-17 | Direct | 4,817 |
Reported balance
Holding disclosure · report date 2026-02-21 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 4,817 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
F2: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2026 Filed Feb 24, 2026 21:56 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 4,150 | $55.58 | $230,658.66 |
DisclosureSEC source: 0001963684-26-000004 · edgardoc.xml · nonDerivative · entry 2 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,222 Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:56 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 2,537 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001963684-26-000004 · edgardoc.xml · derivative · entry 3 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,537 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:56 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 2,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001963684-26-000004 · edgardoc.xml · nonDerivative · entry 1 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 21:50 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 8,324 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001963684-26-000002 · edgardoc.xml · derivative · entry 2 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,324 shares Expires 2026-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest 100% on the first anniversary of the grant date (February 18, 2025). Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 21:50 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 8,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001963684-26-000002 · edgardoc.xml · nonDerivative · entry 1 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:50 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 4,817 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001963684-26-000002 · edgardoc.xml · derivative · entry 3 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,817 Underlying: Common Stock · 4,817 shares Expires 2027-02-17 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest 100% on the first anniversary of the grant date (February 17, 2026). Read SEC document |
| February 21, 2025 Filed Feb 24, 2025 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 1,522 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000011 · edgardoc.xml · derivative · entry 4 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,537 Underlying: Common Stock · 1,522 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively. Read SEC document |
| February 21, 2025 Filed Feb 24, 2025 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 1,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000011 · edgardoc.xml · nonDerivative · entry 2 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 6,973 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000011 · edgardoc.xml · derivative · entry 3 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,973 shares Expires 2025-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest 100% on the first anniversary of the grant date (February 20, 2024). Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 6,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000011 · edgardoc.xml · nonDerivative · entry 1 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:36 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 8,324 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001721515-25-000026 · edgardoc.xml · derivative · entry 2 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,324 Underlying: Common Stock · 8,324 shares Expires 2026-02-18 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest 100% on the first anniversary of the grant date (February 18, 2025). Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 00:19 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 1,016 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001199723-24-000032 · edgardoc.xml · derivative · entry 3 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,059 Underlying: Common Stock · 1,016 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 00:19 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 1,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001199723-24-000032 · edgardoc.xml · nonDerivative · entry 1 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 00:19 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 6,973 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001199723-24-000032 · edgardoc.xml · derivative · entry 2 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,973 Underlying: Common Stock · 6,973 shares Expires 2025-02-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest 100% on the first anniversary of the grant date (February 20, 2024). Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:11 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 5,075 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001963684-23-000004 · edgardoc.xml · derivative · entry 1 Papadimitriou Angelos · CIK 0001963684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,075 Underlying: Common Stock · 5,075 shares Expires 2026-02-21 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.